The Hospitalist – Assistant Professor of Medicine Frank Drescher is interviewed by the Society of Hospital Medicine on his work comparing anticoagulants to aspirin. While Drescher “was surprised to see anticoagulants—often considered the stronger medication—make no difference compared with aspirin in lowering DVT risk with hip and knee replacement surgeries,” he did contend, “that patients’ behavior post-surgery may make a difference.”

Business Standard – Dartmouth researchers including Professor of Microbiology Steve Fiering have found that nanoparticle
can “strengthen the body’s immune system response against tumors.” “Our lab’s approach differs from most in that we use nanoparticles to stimulate the immune system to attack tumors and there are a variety of potential ways that can be done,” said Fiering.

Nature World News – Professor of Microbiology and Immunology Steve Fiering comments more on his recent work on nanoparticles.

NPR – The husband-and-wife team from Dartmouth are on a decade-long mission. They have been pushing the FDA to get useful and readable quantitative data about drugs to doctors and their patients. Schwartz and Woloshin have designed a format they call a drug facts box.

Doctor’s Lounge – A meta-analysis published by Assistant Professor of Medicine Frank Drescher and colleagues is discussed in this article on how “aspirin may be less preferable to other anticoagulants following hip fracture repair,” but more favorable after other types of surgeries.

Vox Conversations – Associate Professor of Medicine Brenda Sirovich argues that the HPV test has a high chance of delivering false positives in women under 30. “It’s much more likely to catch people and label them as diseased or abnormal when in reality, they are going to be just fine,” she says.